Verastem | VSTM - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.38M 172K 2026-03
AstraZeneca USD 1.55B 44K 2026-06
Curis USD 2M 10.93M 2026-03
Cytokinetics USD 124.43M 2.17M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Verastem USD 87.84M 10.1M 2026-03